{"id":"W3169315270","doi":"10.1200/jco.2021.39.15_suppl.4003","title":"Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): Expanded efficacy and safety analyses from CheckMate 577.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Internal medicine; Adjuvant; Adverse effect; Oncology; Discontinuation; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001310962,0.000367705,0.0007974735,0.0002275928,0.000144342,0.000415345,0.0003899641,0.0004122065,0.002646873],"category_scores_gemma":[0.000953282,0.0002036142,0.0009555849,0.0002551314,0.0003545583,0.0002731145,0.0002627571,0.0008703551,0.0002655417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006646861,"about_ca_system_score_gemma":0.0007405631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009439285,"about_ca_topic_score_gemma":0.003693406,"domain_scores_codex":[0.9996934,0.000159602,0.00002951381,0.0000404106,0.00003975928,0.00003729355],"domain_scores_gemma":[0.9994621,0.0001741509,0.0001543221,0.00004565191,0.00003250743,0.0001313624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7682868,0.01384924,0.03750579,0.002211541,0.003249004,0.0002101887,0.0001642565,0.001913568,0.02432314,0.0001663227,0.003300958,0.1448192],"study_design_scores_gemma":[0.4059538,0.4063686,0.1589111,0.0004081628,0.006619025,0.0006221232,0.0001408781,0.002919827,0.01010524,0.0002430213,0.00764941,0.00005886471],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962628,0.00183333,0.0001307349,0.0001002448,0.00003412844,0.0003631326,0.0005986401,0.00001403835,0.0006629509],"genre_scores_gemma":[0.9953288,0.001531989,0.0003622201,0.000256603,0.00005296677,0.0003623747,0.001467534,0.000005470961,0.0006322131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002646873,"threshold_uncertainty_score":0.008854628,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1770054908033701,"score_gpt":0.5273111111710322,"score_spread":0.3503056203676622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}